Looking back at the UPC’s ‘successful’ first year

Court seen as “exceeding expectations” | Experts urge caution, emphasising that confident and reliable court judgments are needed | High-stakes patent litigation, especially in pharmaceuticals, remains predominantly within national courts.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com

More on this story

Careers

K&L Gates expands European practice with Munich team hire

5 August 2026 Strategic addition marks the latest investment in the firm’s European platform as demand for cross-border patent expertise continues to grow.

MedTech

Insulet asks Fed Circ to rehear $59.4m trade secret reversal

3 August 2026 The medical device maker says that a split appellate decision raises broader questions about trade secret law, jurisdiction and when the clock starts ticking on misappropriation claims.

Careers

Arnold & Porter adds firepower to ITC practice with new partner hire

3 August 2026 Appointment strengthens the firm’s expertise in US International Trade Commission proceedings and cross-border intellectual property disputes.

More features

K&L Gates expands European practice with Munich team hire

Exclusive: Winston Taylor’s UK head of IP on pitching $1.75bn firm’s ‘humble, but lethal’ practice

Insulet asks Fed Circ to rehear $59.4m trade secret reversal

Arnold & Porter adds firepower to ITC practice with new partner hire

USPTO director steps into Sun Pharma’s PTAB-ITC clash

USPTO appoints new acting commissioner for patents

European court strikes down hearing aid sensor patent

Where Big Pharma is betting big in the M&A boom

Looking back at the UPC’s ‘successful’ first year

More on this story

Editor's picks

Editor's picks

More features